BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28675123)

  • 21. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways.
    Chang JH; Lai SL; Chen WS; Hung WY; Chow JM; Hsiao M; Lee WJ; Chien MH
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1746-1758. PubMed ID: 28648644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
    Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
    Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
    Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
    Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.
    Fritzsche FR; Wassermann K; Jung M; Tölle A; Kristiansen I; Lein M; Johannsen M; Dietel M; Jung K; Kristiansen G
    BMC Cancer; 2008 Jun; 8():179. PubMed ID: 18582378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma.
    Lin YS; Kuo TT; Lo CC; Cheng WC; Chang WC; Tseng GC; Bai ST; Huang YK; Hsieh CY; Hsu HS; Jiang YF; Lin CY; Lai LC; Li XG; Sher YP
    Int J Biol Sci; 2021; 17(14):3898-3910. PubMed ID: 34671207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAM9 silencing inhibits breast tumor cell invasion in vitro.
    Micocci KC; Martin AC; Montenegro Cde F; Durante AC; Pouliot N; Cominetti MR; Selistre-de-Araujo HS
    Biochimie; 2013 Jul; 95(7):1371-8. PubMed ID: 23499592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Par3 promotes lung adenocarcinoma metastasis through 14-3-3ζ protein.
    Song T; Tian X; Kai F; Ke J; Wei Z; Jing-Song L; Si-Hua W; Jian-Jun W
    Oncotarget; 2016 Sep; 7(39):64260-64273. PubMed ID: 27588399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
    Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
    Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
    Chou CW; Huang YK; Kuo TT; Liu JP; Sher YP
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
    Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
    Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
    Fritzsche FR; Jung M; Tölle A; Wild P; Hartmann A; Wassermann K; Rabien A; Lein M; Dietel M; Pilarsky C; Calvano D; Grützmann R; Jung K; Kristiansen G
    Eur Urol; 2008 Nov; 54(5):1097-106. PubMed ID: 18061337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
    Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
    Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
    Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
    Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
    Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma.
    Cai M; Wang Z; Zhang J; Zhou H; Jin L; Bai R; Weng Y
    Cell Physiol Biochem; 2015; 36(3):1175-85. PubMed ID: 26111641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.
    Liu CM; Hsieh CL; He YC; Lo SJ; Liang JA; Hsieh TF; Josson S; Chung LW; Hung MC; Sung SY
    PLoS One; 2013; 8(1):e53795. PubMed ID: 23342005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.